Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina
Condition:   Yellow Fever Intervention:   Biological: Serological study after yellow fever vaccination Sponsors:   Ministry of Public Health, Argentina;   Centers for Disease Control and Prevention;   Pan American Health Organization Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials